The Medical Product Development Program (MPDP) is administered by BioAlberta and jointly funded by the Governments of Canada and Alberta through the Canada-Alberta Western Economic Partnership Agreement. The MPDP helps Alberta companies develop and commercialize new medical devices and applications.
The MPDP funds approved early-stage medical product development projects on a 3-1 basis. For every three program dollars, participating companies contribute one dollar to the total project budget. On a $100,000 project for example, MPDP would contribute $75,000 and the company would contribute $25,000.
An external expert review panel will approve and allocate the total pool of funds to a select group of projects with total project budgets that may range from $25,000 to a maximum of $100,000.
MPDP Round 1 has a total of approximately $200,000 available for project funding.
Please click here for complete program guidelines.
Please click here to read the news release announcing the launch of the 2009/10 project round.
For more information, contact: